Related Experiment Video
Updated: Mar 2, 2026
05:19
Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment
Published on: July 7, 2023
3.6K
Closed-loop neuromodulation systems: next-generation treatments for psychiatric illness
1a Department of Psychiatry , Massachusetts General Hospital , Charlestown , MA , USA.
International Review of Psychiatry (Abingdon, England)
|May 20, 2017
Summary
Closed-loop deep brain stimulation offers personalized psychiatric treatment by adjusting therapy based on brain activity. This approach aims to overcome inconsistent outcomes and improve patient-specific results for treatment-resistant conditions.
Area of Science:
- Neuroscience
- Psychiatry
- Biomedical Engineering
Background:
- Deep brain stimulation (DBS) shows promise for psychiatric disorders, but clinical outcomes are inconsistent.
- Closed-loop neuromodulation, which adjusts stimulation based on real-time brain activity, offers a path to more precise, patient-specific treatments.
- Existing closed-loop platforms are effective in epilepsy and movement disorders, but their psychiatric applications require further investigation.
Purpose of the Study:
- To review current closed-loop neuromodulation platforms for psychiatric applications.
- To discuss the limitations of existing technologies and emerging solutions.
- To explore the integration of closed-loop neuromodulation with the Research Domain Criteria (RDoC) framework for treatment-resistant psychiatric illnesses.
Main Methods:
- Review of available closed-loop neuromodulation platforms and their efficacy in neurological and psychiatric disorders.
- Discussion of pre-clinical developments, including wireless deep neurostimulation and genetically targeted neuromodulation.
- Analysis of challenges in identifying biomarkers for closed-loop psychiatric brain stimulation, considering the RDoC framework.
Main Results:
- Closed-loop neuromodulation platforms demonstrate efficacy in epilepsy and movement disorders.
- Emerging technologies like wireless and genetically targeted neuromodulation aim to address current limitations.
- Identifying reliable biomarkers for titration remains a significant challenge for psychiatric applications.
Conclusions:
- Closed-loop neuromodulation holds potential for personalized psychiatric treatment, but requires further development.
- Integrating neuromodulation with the RDoC framework may provide a structured approach to understanding and treating complex psychiatric conditions.
- Addressing biomarker challenges is crucial for advancing closed-loop brain stimulation in psychiatry.
Related Concept Videos
01:30Psychosurgery
2.1K
Psychosurgery, the surgical alteration or permanent removal of brain tissue to alleviate severe psychological conditions, stands as one of the most radical and controversial treatments in the history of mental health care. Its development and application have evolved significantly, marked by dramatic shifts in scientific understanding and ethical perspectives.
Historical Development of Psychosurgery
In the 1930s, Portuguese neurologist Antonio Egas Moniz introduced a surgical procedure designed...
Historical Development of Psychosurgery
In the 1930s, Portuguese neurologist Antonio Egas Moniz introduced a surgical procedure designed...
2.1K
01:26Psychosis: Goals of Pharmacotherapy
642
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
642